Next 10 |
2024-05-17 10:55:05 ET Alpha Teknova, Inc. (TKNO) Q1 2024 Earnings Conference Call May 13, 2024, 5:00 PM ET Company Participants Jennifer Henry - Senior Vice President of Marketing Stephen Gunstream - President and Chief Executive Officer Matthew Lowell - Chief F...
2024-05-13 17:06:48 ET More on Alpha Teknova Alpha Teknova, Inc. (TKNO) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Alpha Teknova Historical earnings data for Alpha Teknova Financial information for Alpha Teknova Read the...
First quarter 2024 total revenue was $9.3 million, up 2% from prior year Launch of Build-Tek™ Custom Configurator Company reaffirms 2024 revenue guidance of $35-38 million HOLLISTER, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”...
Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...
First-of-its-kind custom configurator – available today – gives scientists access to high quality, customizable buffers in small volumes for use in early-stage experiments, all with exceptionally short turnaround times Novel, multi-purpose AAV stabilizer solution increases cap...
HOLLISTER, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Compa...
2024-03-12 06:33:06 ET Alpha Teknova, Inc. (TKNO) Q4 2023 Earnings Conference Call March 11, 2024, 05:30 PM ET Company Participants Jennifer Henry - Senior Vice President of Marketing Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Ch...
2024-03-11 16:03:41 ET More on Alpha Teknova Read the full article on Seeking Alpha For further details see: Alpha Teknova GAAP EPS of -$0.26 misses by $0.02, revenue of $7.9M misses by $0.42M
Full year 2023 total revenue was $36.7 million, down 11% year-over-year Achieved 36% annual growth in the number of Clinical Solutions customers in 2023 Company provides 2024 revenue guidance of $35-38 million HOLLISTER, Calif., March 11, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, ...
Volcon Inc. (VLCN) is expected to report for Q4 2023 Tenaga Nasional Bhd ADR (TNABY) is expected to report for quarter end 2023-12-31 Hesai Group (HSAI) is expected to report for Q4 2023 Intrusion Inc. (INTZ) is expected to report $-0.14 for Q4 2023 Eliem Therapeutics Inc (ELYM) i...
News, Short Squeeze, Breakout and More Instantly...
Alpha Teknova Inc. Company Name:
TKNO Stock Symbol:
NASDAQ Market:
First quarter 2024 total revenue was $9.3 million, up 2% from prior year Launch of Build-Tek™ Custom Configurator Company reaffirms 2024 revenue guidance of $35-38 million HOLLISTER, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”...
Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...
First-of-its-kind custom configurator – available today – gives scientists access to high quality, customizable buffers in small volumes for use in early-stage experiments, all with exceptionally short turnaround times Novel, multi-purpose AAV stabilizer solution increases cap...